Skip to content

GAIN CLARITY AT SPEED.

FOR WHAT MATTERS

Better gray-white matter contrast and more efficient reads from 30% faster scans on all 1.5T and 3T magnets. All from fully sampled data.

Contact Us

Acquire images faster per machine per day

STAGE™ reduces the time for MRI brain protocols by 30% for your most common procedures, adding an extra 90–120 minutes of MRI scan time per day.

Your STAGE™ for better MRI imaging

The STAGE™ platform improves the images from your MRI machines without extending scan times. In fact, with STAGE™, you can scan up to 30% faster while gaining enhanced visualization with fully sampled quantitative data.

More exams, greater throughput

STAGE™ reduces the time for MRI brain protocols by 30% for your most common procedures, making an additional 90–120 minutes per day available for more scans on each MRI machine.

Clearer images, quantifiable output

Get greater clarity and contrast from your images—and more. STAGE™ acquires fully sampled quantitative data for confident diagnoses and to track disease progression and treatment efficacy with greater accuracy.

Works with a wide range of MRI machines

Physics-based STAGE™ was developed independently of MRI manufacturers, requires no dedicated hardware and integrates seamlessly with virtually all 1.5 and 3T scanners regardless of brand or model.

STAGE™ INTEGRATES WITH LEADING MRI MACHINES

Siemens
General Electric
Philips
Canon
United Imaging

MRI: Head scan

Ex:29942

Se:8

Im:4

Clearly better results with STAGE

CONVENTIONAL T1W
STAGE T1W
CONVENTIONAL SWI
STAGE SWI
CONVENTIONAL T2W
STAGE T2W
See the difference that fully sampled data acquired with physics-based STAGE™ makes.

MRI: Head scan

Ex:29942

Se:8

Im:4

USE CASES

Learn More

STAGE™ multiparametric maps provide enhanced visualization to differentiate tumor tissue, changes occurring in surrounding tissue, and tumor-associated blood products. Additionally, STAGE™ enables measurement of T1 and PD properties related to water content changes and leaky blood vessels, and improved visualization of cerebral microbleeds resulting from radiation therapy.

News

All News

News

ASN 2023: The Arrival of Practical QSM Tools Enhanced for Everyday Clinical Practice

Attendees at this year’s American Society of Neuroimaging annual meeting will have their first opportunity to see and hear how quantitative MRI (qMRI) and quantitative susceptibility mapping (QSM) tools are now practical for – and being used in — everyday clinical practice. QSM is just one of the advanced outputs available with STAGE and is“ASN 2023: The Arrival of Practical QSM Tools Enhanced for Everyday Clinical Practice”

read more

News

Health system priorities for AI and two important questions for radiology leaders

A new report from UPMC’s Center for Connected Medicine and KLAS Research about the AI use cases that health systems are prioritizing over the next few years includes findings about plans for radiology AI that raise two important questions for neuroradiologists and healthcare leaders: Based on a survey of 58 executives and senior managers at“Health system priorities for AI and two important questions for radiology leaders”

read more

News

STAGE and the Promise and Challenges of New Alzheimer’s Drug Therapies

Radiologists, neurologists, Alzheimer’s patients and their families are rightfully encouraged by the range of new drugs in development to slow or reduce cognitive decline. At the start of 2023 there were 187 trials for 141 drugs addressing Alzheimer’s pathologies. Two drugs, aducanumab and lecanemab, have received accelerated FDA approval in the past two years. A“STAGE and the Promise and Challenges of New Alzheimer’s Drug Therapies”

read more

SpinTech MRI

30200 Telegraph Rd., Suite 140
Bingham Farms, MI 48025

Email: info@spintechmri.com

Tel: +1 (248) 712 6789